COMPOUND BEARING BETA-GALACTOSIDE-INTRODUCED SELF-IMMOLATIVE LINKER
The present invention relates to a compound bearing a self-immolative linker having β-galactoside introduced thereto. In a compound bearing a β-galactoside-introduced self-immolative linker according to the present invention, particularly, the self-immolative linker may form a glycosidic bond with a...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French Korean |
Published |
23.08.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a compound bearing a self-immolative linker having β-galactoside introduced thereto. In a compound bearing a β-galactoside-introduced self-immolative linker according to the present invention, particularly, the self-immolative linker may form a glycosidic bond with a protein (e.g., an oligopeptide, a polypeptide, an antibody, etc.) or ligand which has specific affinity for a desired target or with an active agent (e.g., a drug, a toxin, a ligand, a detection probe, etc.) which has a specific function or activity so as to allow the selective release of the active agent within a target cell.
La présente invention concerne un composé portant un lieur auto-immolable dans lequel du bêta-galactoside est introduit. Dans un composé portant un lieur auto-immolable à bêta-galactoside introduit selon la présente invention, en particulier, le lieur auto-immolable peut former une liaison glycosidique avec une protéine (par exemple, un oligopeptide, un polypeptide, un anticorps, etc.) ou un ligand qui a une affinité spécifique pour une cible souhaitée ou avec un agent actif (par exemple, un médicament, une toxine, un ligand, une sonde de détection, etc.) qui a une fonction ou une activité spécifique de façon à permettre la libération sélective de l'agent actif à l'intérieur d'une cellule cible.
본 발명은 β-갈락토사이드(β-galactoside)가 도입된 자가-희생 기(self-immolative linker)를 포함하는 화합물에 관한 것으로, 보다 상세하게는 본 발명의 β-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물은 목적하는 표적에 대한 결합 특이성을 갖는 단백질(예: 올리고펩티드, 폴리펩티드, 항체 등) 또는 리간드, 특이적 기능 또는 활성을 갖는 활성제(예: 약물, 독소, 리간드, 검출용 탐침 등) 및 타겟 세포내에서 선택적으로 활성제가 방출될 수 있도록 글라이코사이드 결합(glycosidic bond)을 이루고 있는 자가-희생 기를 포함할 수 있다. |
---|---|
Bibliography: | Application Number: WO2017KR15613 |